294 related articles for article (PubMed ID: 31019051)
1. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
3. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
J Virol; 2020 May; 94(10):. PubMed ID: 32132242
[TBL] [Abstract][Full Text] [Related]
4. A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth.
Wang C; Liu X; Liang J; Narita Y; Ding W; Li D; Zhang L; Wang H; Leong MML; Hou I; Gerdt C; Jiang C; Zhong Q; Tang Z; Forney C; Kottyan L; Weirauch MT; Gewurz BE; Zeng MS; Jiang S; Teng M; Zhao B
Nat Commun; 2023 Mar; 14(1):1598. PubMed ID: 36949074
[TBL] [Abstract][Full Text] [Related]
5. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism.
Lamontagne RJ; Soldan SS; Su C; Wiedmer A; Won KJ; Lu F; Goldman AR; Wickramasinghe J; Tang HY; Speicher DW; Showe L; Kossenkov AV; Lieberman PM
PLoS Pathog; 2021 Jan; 17(1):e1009208. PubMed ID: 33497421
[TBL] [Abstract][Full Text] [Related]
6. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
7. Modulating Gene Expression in Epstein-Barr Virus (EBV)-Positive B Cell Lines with CRISPRa and CRISPRi.
Wang LW; Trudeau SJ; Wang C; Gerdt C; Jiang S; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.13.1-31.13.18. PubMed ID: 29337370
[TBL] [Abstract][Full Text] [Related]
8. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.
Ma Y; Walsh MJ; Bernhardt K; Ashbaugh CW; Trudeau SJ; Ashbaugh IY; Jiang S; Jiang C; Zhao B; Root DE; Doench JG; Gewurz BE
Cell Host Microbe; 2017 May; 21(5):580-591.e7. PubMed ID: 28494239
[TBL] [Abstract][Full Text] [Related]
10. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
[TBL] [Abstract][Full Text] [Related]
11. Host genetic variants and gene expression patterns associated with Epstein-Barr virus copy number in lymphoblastoid cell lines.
Houldcroft CJ; Petrova V; Liu JZ; Frampton D; Anderson CA; Gall A; Kellam P
PLoS One; 2014; 9(10):e108384. PubMed ID: 25290448
[TBL] [Abstract][Full Text] [Related]
12. Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.
Viel KCMF; Parameswaran S; Donmez OA; Forney CR; Hass MR; Yin C; Jones SH; Prosser HK; Diouf AA; Gittens OE; Edsall LE; Chen X; Rowden H; Dunn KA; Guo R; VonHandorf A; Leong MML; Ernst K; Kaufman KM; Lawson LP; Gewurz B; Zhao B; Kottyan LC; Weirauch MT
BMC Genomics; 2024 Mar; 25(1):273. PubMed ID: 38475709
[TBL] [Abstract][Full Text] [Related]
13. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
Yoshioka M; Crum MM; Sample JT
J Virol; 2008 Feb; 82(4):1679-87. PubMed ID: 18077719
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
15. Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein-Barr Virus hypomethylated regions.
Ong LTC; Parnell GP; Afrasiabi A; Stewart GJ; Swaminathan S; Booth DR
Genes Immun; 2020 Feb; 21(2):91-99. PubMed ID: 31619767
[TBL] [Abstract][Full Text] [Related]
16. CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms.
Djavadian R; Hayes M; Johannsen E
PLoS Pathog; 2018 Jun; 14(6):e1007114. PubMed ID: 29864140
[TBL] [Abstract][Full Text] [Related]
17. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
Yu X; Wang Z; Mertz JE
PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase.
Kashuba E; Kashuba V; Sandalova T; Klein G; Szekely L
BMC Cell Biol; 2002 Aug; 3():23. PubMed ID: 12199906
[TBL] [Abstract][Full Text] [Related]
19. Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.
Berthomé M; Gallot G; Vivien R; Clémenceau B; Nguyen JM; Coste-Burel M; Vié H
Cancer Immunol Immunother; 2010 Dec; 59(12):1867-75. PubMed ID: 20809356
[TBL] [Abstract][Full Text] [Related]
20. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.
Yang L; Hakoda M; Iwabuchi K; Takeda T; Koike T; Kamatani N; Takada K
J Virol; 2004 Sep; 78(18):9918-23. PubMed ID: 15331725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
